BioCardia Inc (NASDAQ:BCDA)
| 1.45 Delayed Data As of Aug 05 |  +0.01 / +0.69%Today’s Change | 1.10 Today|||52-Week Range 3.96 | -25.26% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $26.7M |
Company Description
BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brands. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Contact Information
BioCardia, Inc. 320 Soquel Way Sunnyvale California 94085 |
Employees
Shareholders
| Mutual fund holders | 7.59% |
| Individual stakeholders | 16.58% |
| Other institutional | 13.68% |
Top Executives
| Peter Alan Altman | President, Chief Executive Officer & Director |
| David McClung | Chief Financial Officer |
| Ian McNiece | Chief Scientific Officer |
| Sujith Shetty | Chief Medical Officer |
| Debby Holmes-Higgin | Vice President-Clinical & Study Recruiting |
